{"id":21348,"date":"2021-03-16T18:25:26","date_gmt":"2021-03-16T22:25:26","guid":{"rendered":"https:\/\/annsvg.com\/?p=21348&#038;preview=true&#038;preview_id=21348"},"modified":"2021-03-16T18:18:42","modified_gmt":"2021-03-16T22:18:42","slug":"eu-regulator-convinced-astrazeneca-benefit-outweighs-risk","status":"publish","type":"post","link":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/","title":{"rendered":"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">BRUSSELS (AP) \u2014 The European Union\u2019s drug regulator insisted Tuesday that there is \u201cno indication\u201d the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to save lives or suspend its use over reports of clotting in some recipients.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The European Medicines Agency urged governments not to halt use of the vaccine at a time when the pandemic is still taking thousands of lives each day. And already there are concerns that even brief suspensions could have disastrous effects on confidence in inoculation campaigns the world over, many of which are already struggling to overcome logistical hurdles and widespread hesitancy about vaccines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cWe are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing COVID-19 with its associated risk of hospitalization and death outweigh the risk of the side effects,\u201d said Emer Cooke, the head of the agency.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Many scientists have argued that even the loss of a few days in vaccinating vulnerable people could be far costlier than the impact of any rare phenomenon.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">But a cascading number of countries have taken a different view and locked away shots from the Anglo-Swedish company, awaiting the results of an EMA review, promised Thursday.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sweden was the latest to do so Tuesday, choosing caution over speed, even as Cooke insisted \u201cthat at present there is no indication that vaccination has caused these conditions.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Highlighting the difficulty of making such decisions at a time when people are voraciously following the ups and downs of every vaccine candidate, Sweden\u2019s state epidemiologist Anders Tegnell said that the risk, if it existed, was rare but the country\u2019s authorities \u201chave felt compelled to pause AstraZeneca\u2019s vaccine\u201d after receiving ever more reports of blood clots.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Europe has the luxury to be able to pick from several vaccine candidates \u2014 but the decision of whether to suspend use of the vaccine is still not an easy one on the continent where the virus has already killed over half a million people, is surging again and where the vaccination campaign has repeatedly stumbled.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The choice may be even more fraught elsewhere because many countries are relying heavily on AstraZeneca, which is cheaper and easier to handle than some other shots. The vaccine has so far played a huge role in the global initiative to ensure vaccines get to poorer countries known as COVAX.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For instance, when Congo decided to hold off on the vaccine, it put its entire campaign on hold before it even began since it has not yet received doses of any other shot. Somalia, by contrast, went ahead with its first shots of AstraZeneca on Tuesday \u2014 including one for the health minister, who received the jab publicly to reassure the nation about its safety.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The AstraZeneca shot has already struggled to gain public trust after troubles with reporting of its data and concerns about its effectiveness in older people. More than half of the 15 million AstraZeneca doses delivered to the EU\u2019s 27 member states are still lying in storage, according to data compiled by the European Center for Disease Prevention and Control.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The current debate could further erode confidence in the vaccine \u2014 and that skepticism could even spread to others.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cWe are worried that there may be an effect on the trust of the vaccines. But our job is to make sure that the products that we authorize are safe,\u201d Cooke said.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The EMA chief noted that thousands of people across the EU develop blood clots every year for a variety of reasons and that there were no reports of increased clotting incidents in the clinical studies of the AstraZeneca vaccine. Still, experts would undertake a \u201cvery rigorous analysis\u201d and make a recommendation Thursday.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The difficulty of the decision was clear in Thailand, the first country outside Europe to temporarily suspend use of the AstraZeneca vaccine, only to recant on Tuesday \u2014 when its prime minister received a dose.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThere are people who have concerns,\u201d Prayuth Chan-ocha said after getting the shot. \u201cBut we must believe doctors, believe in our medical professionals.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Many other countries in Asia have likewise shrugged off concerns, but Indonesia, a nation of over a quarter-billion people, halted use of the shot this week, saying it would wait for a World Health Organization report on the issue.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In addition to the EMA, AstraZeneca and the WHO have said there is no evidence the vaccine carries an increased risk of blood clots. There have been 37 reports of blood clots among the more than 17 million people who have received the vaccine across the EU and Britain, the company said.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThis is much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed COVID-19 vaccines,\u201d the drugmaker said.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">But the number of countries in the bloc that are sticking with the shot is falling after heavyweights like Germany, Italy, France and Spain all said they were suspending it.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">That left Belgium \u2014 and a handful of others such as Poland, Romania and Greece \u2014 increasingly isolated in their insistence that halting the shots now would cause more harm than the side effects so hotly debated.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cWhen you know how the virus is making the rounds, it would be very imprudent to stop,\u201d Belgian Health Minister Frank Vandenbroucke told VRT network early Tuesday.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Experts have noted that such concerns are inevitable in mass vaccination campaigns \u2014 with so many people getting shots, some are bound to get sick even if the vaccine is not to blame. That would mean \u201cwe\u2019d have to incessantly interrupt campaigns during the coming months,\u201d Vandenbroucke said.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Still, the torrent of decisions casting doubt on the AstraZeneca vaccine despite assurances of experts is testing public opinion.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">But Bogdan Grecu, 26, who works in Romania\u2019s petroleum sector, was unfazed when he got his shot Tuesday.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cI\u2019m pretty sure it\u2019s worth the risk,\u201d he said. \u201cI don\u2019t think it\u2019s possible for the vaccine to create a worse reaction than the virus.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BRUSSELS (AP) \u2014 The European Union\u2019s drug regulator insisted Tuesday that there is \u201cno indication\u201d the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to save lives or suspend its use over reports of clotting in some recipients. The European Medicines Agency<\/p>\n","protected":false},"author":8,"featured_media":21216,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[6],"tags":[],"class_list":["post-21348","post","type-post","status-publish","format-standard","has-post-thumbnail","category-regional-and-international-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk - Asberth News Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk - Asberth News Network\" \/>\n<meta property=\"og:description\" content=\"BRUSSELS (AP) \u2014 The European Union\u2019s drug regulator insisted Tuesday that there is \u201cno indication\u201d the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to save lives or suspend its use over reports of clotting in some recipients. The European Medicines Agency\" \/>\n<meta property=\"og:url\" content=\"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/\" \/>\n<meta property=\"og:site_name\" content=\"Asberth News Network\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/asbertnewsnetwork\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T22:25:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/annsvg.com\/the-content\/uploads\/2021\/03\/img_8184.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"280\" \/>\n\t<meta property=\"og:image:height\" content=\"178\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Maurice John\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AsbertNews\" \/>\n<meta name=\"twitter:site\" content=\"@AsbertNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maurice John\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/\"},\"author\":{\"name\":\"Maurice John\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/#\\\/schema\\\/person\\\/05927ad0b35f70c549c856744bc0b21a\"},\"headline\":\"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk\",\"datePublished\":\"2021-03-16T22:25:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/\"},\"wordCount\":1012,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/annsvg.com\\\/the-content\\\/uploads\\\/2021\\\/03\\\/img_8184.jpg\",\"articleSection\":[\"Regional\\\/International News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/\",\"url\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/\",\"name\":\"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk - Asberth News Network\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/annsvg.com\\\/the-content\\\/uploads\\\/2021\\\/03\\\/img_8184.jpg\",\"datePublished\":\"2021-03-16T22:25:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/annsvg.com\\\/the-content\\\/uploads\\\/2021\\\/03\\\/img_8184.jpg\",\"contentUrl\":\"https:\\\/\\\/annsvg.com\\\/the-content\\\/uploads\\\/2021\\\/03\\\/img_8184.jpg\",\"width\":280,\"height\":178},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/2021\\\/03\\\/16\\\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/annsvg.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/#website\",\"url\":\"https:\\\/\\\/annsvg.com\\\/\",\"name\":\"Asberth News Network\",\"description\":\"Tomorrow News. Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/annsvg.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/#organization\",\"name\":\"Asbert News Network\",\"url\":\"https:\\\/\\\/annsvg.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/annsvg.com\\\/the-content\\\/uploads\\\/2019\\\/10\\\/logoann.png\",\"contentUrl\":\"https:\\\/\\\/annsvg.com\\\/the-content\\\/uploads\\\/2019\\\/10\\\/logoann.png\",\"width\":640,\"height\":295,\"caption\":\"Asbert News Network\"},\"image\":{\"@id\":\"https:\\\/\\\/annsvg.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/asbertnewsnetwork\",\"https:\\\/\\\/x.com\\\/AsbertNews\",\"https:\\\/\\\/www.instagram.com\\\/asbertnews\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/#\\\/schema\\\/person\\\/05927ad0b35f70c549c856744bc0b21a\",\"name\":\"Maurice John\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/annsvg.com\\\/the-content\\\/litespeed\\\/avatar\\\/13f65a825b92469e47a9d96bce5fe9a9.jpg?ver=1794850720\",\"url\":\"https:\\\/\\\/annsvg.com\\\/the-content\\\/litespeed\\\/avatar\\\/13f65a825b92469e47a9d96bce5fe9a9.jpg?ver=1794850720\",\"contentUrl\":\"https:\\\/\\\/annsvg.com\\\/the-content\\\/litespeed\\\/avatar\\\/13f65a825b92469e47a9d96bce5fe9a9.jpg?ver=1794850720\",\"caption\":\"Maurice John\"},\"url\":\"https:\\\/\\\/annsvg.com\\\/index.php\\\/author\\\/mauricejohn\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk - Asberth News Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/","og_locale":"en_US","og_type":"article","og_title":"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk - Asberth News Network","og_description":"BRUSSELS (AP) \u2014 The European Union\u2019s drug regulator insisted Tuesday that there is \u201cno indication\u201d the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to save lives or suspend its use over reports of clotting in some recipients. The European Medicines Agency","og_url":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/","og_site_name":"Asberth News Network","article_publisher":"https:\/\/www.facebook.com\/asbertnewsnetwork","article_published_time":"2021-03-16T22:25:26+00:00","og_image":[{"width":280,"height":178,"url":"https:\/\/annsvg.com\/the-content\/uploads\/2021\/03\/img_8184.jpg","type":"image\/jpeg"}],"author":"Maurice John","twitter_card":"summary_large_image","twitter_creator":"@AsbertNews","twitter_site":"@AsbertNews","twitter_misc":{"Written by":"Maurice John","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/#article","isPartOf":{"@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/"},"author":{"name":"Maurice John","@id":"https:\/\/annsvg.com\/#\/schema\/person\/05927ad0b35f70c549c856744bc0b21a"},"headline":"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk","datePublished":"2021-03-16T22:25:26+00:00","mainEntityOfPage":{"@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/"},"wordCount":1012,"commentCount":0,"publisher":{"@id":"https:\/\/annsvg.com\/#organization"},"image":{"@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/annsvg.com\/the-content\/uploads\/2021\/03\/img_8184.jpg","articleSection":["Regional\/International News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/","url":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/","name":"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk - Asberth News Network","isPartOf":{"@id":"https:\/\/annsvg.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/#primaryimage"},"image":{"@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/#primaryimage"},"thumbnailUrl":"https:\/\/annsvg.com\/the-content\/uploads\/2021\/03\/img_8184.jpg","datePublished":"2021-03-16T22:25:26+00:00","breadcrumb":{"@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/#primaryimage","url":"https:\/\/annsvg.com\/the-content\/uploads\/2021\/03\/img_8184.jpg","contentUrl":"https:\/\/annsvg.com\/the-content\/uploads\/2021\/03\/img_8184.jpg","width":280,"height":178},{"@type":"BreadcrumbList","@id":"https:\/\/annsvg.com\/index.php\/2021\/03\/16\/eu-regulator-convinced-astrazeneca-benefit-outweighs-risk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/annsvg.com\/"},{"@type":"ListItem","position":2,"name":"EU regulator \u2018convinced\u2019 AstraZeneca benefit outweighs risk"}]},{"@type":"WebSite","@id":"https:\/\/annsvg.com\/#website","url":"https:\/\/annsvg.com\/","name":"Asberth News Network","description":"Tomorrow News. Today","publisher":{"@id":"https:\/\/annsvg.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/annsvg.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/annsvg.com\/#organization","name":"Asbert News Network","url":"https:\/\/annsvg.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/annsvg.com\/#\/schema\/logo\/image\/","url":"https:\/\/annsvg.com\/the-content\/uploads\/2019\/10\/logoann.png","contentUrl":"https:\/\/annsvg.com\/the-content\/uploads\/2019\/10\/logoann.png","width":640,"height":295,"caption":"Asbert News Network"},"image":{"@id":"https:\/\/annsvg.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/asbertnewsnetwork","https:\/\/x.com\/AsbertNews","https:\/\/www.instagram.com\/asbertnews\/"]},{"@type":"Person","@id":"https:\/\/annsvg.com\/#\/schema\/person\/05927ad0b35f70c549c856744bc0b21a","name":"Maurice John","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/annsvg.com\/the-content\/litespeed\/avatar\/13f65a825b92469e47a9d96bce5fe9a9.jpg?ver=1794850720","url":"https:\/\/annsvg.com\/the-content\/litespeed\/avatar\/13f65a825b92469e47a9d96bce5fe9a9.jpg?ver=1794850720","contentUrl":"https:\/\/annsvg.com\/the-content\/litespeed\/avatar\/13f65a825b92469e47a9d96bce5fe9a9.jpg?ver=1794850720","caption":"Maurice John"},"url":"https:\/\/annsvg.com\/index.php\/author\/mauricejohn\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/annsvg.com\/the-content\/uploads\/2021\/03\/img_8184.jpg","_links":{"self":[{"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/posts\/21348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/comments?post=21348"}],"version-history":[{"count":1,"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/posts\/21348\/revisions"}],"predecessor-version":[{"id":21349,"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/posts\/21348\/revisions\/21349"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/media\/21216"}],"wp:attachment":[{"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/media?parent=21348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/categories?post=21348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/annsvg.com\/index.php\/wp-json\/wp\/v2\/tags?post=21348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}